GE HealthCare price target lowered to $84 from $88 at Citi
Citi lowered the firm’s price target on GE HealthCare (GEHC) to $84 from $88 and keeps a Neutral rating on the shares. The firm adjusted targets in the medical technology group post the Q4 reports. Sector fundamentals remain “healthy” despite the recent volatility, the analyst tells investors in a research note. Citi’s top picks are iRhythm and Medtronic.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Read More on GEHC:
Disclaimer & DisclosureReport an Issue
- GE HealthCare announces FDA clearance for View
- GE Healthcare Advances Sonazoid Trial in Paediatric Liver Imaging: What Investors Should Watch
- GE HealthCare price target raised to $95 from $90 at Argus
- GE HealthCare Establishes New 364-Day Revolving Credit Facility
- nVent adds Mellinda Devese as Chief Supply Chain Officer
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CFTC officials who questioned prediction markets were suspended: NYT
Cardano governance fight grows as Hoskinson audits 11,000 DAOs
Top Crypto Investor Says This Update Is Massively Bullish for XRP Holders
Analyst: Bitcoin Has Lost Structural Bullish Momentum, Market in Risk-Off Mode
Trending news
MoreCrypto prices
More
